Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Barbier-Torres L, Fortner KA, Iruzubieta P, Delgado TC, Giddings E, Chen Y, Champagne D, Fern?ndez-Ramos D, Mestre D, Gomez-Santos B, Varela-Rey M, de Juan VG, Fern?ndez-Tussy P, Zubiete-Franco I, Garc?a-Monz?n C, Gonz?lez-Rodr?guez ?, Oza D, Valen?a-Pereira F, Fang Q, Crespo J, Aspichueta P, Tremblay F, Christensen BC, Anguita J, Mart?nez-Chantar ML, Rinc?n M. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat Commun. 2020 07 03; 11(1):3360.